PRMB:NYSEPrimo Brands Corporation Analysis
Data as of 2026-06-07 - not real-time
$22.95
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Primo Brands is currently trading below its short‑term momentum gauge, with the price sitting beneath the 20‑day moving average while still above the 50‑day level, indicating a mixed technical picture. The MACD histogram remains in negative territory and the signal line suggests bearish momentum, yet the overall trend is still classified as bullish and the RSI hovers around a neutral midpoint. Volatility is notably elevated, and the stock’s beta points to modest sensitivity to broader market moves. Fundamentally, the valuation appears stretched as the trailing PE is exceptionally high, though the forward PE contracts sharply, hinting at potential earnings improvement. The dividend payout exceeds earnings, raising concerns about the sustainability of the current yield. Additionally, the balance sheet is heavily leveraged with a debt‑to‑equity ratio well above industry norms, while analyst consensus remains positive with a target price that suggests modest upside.
Given the convergence of technical weakness, high leverage, and dividend sustainability issues, investors should approach the stock cautiously. The upside potential is limited unless earnings accelerate and the capital structure improves, but the brand portfolio and defensive consumer positioning provide a degree of resilience. Monitoring margin trends and any deleveraging actions will be key to reassessing the investment case.
Given the convergence of technical weakness, high leverage, and dividend sustainability issues, investors should approach the stock cautiously. The upside potential is limited unless earnings accelerate and the capital structure improves, but the brand portfolio and defensive consumer positioning provide a degree of resilience. Monitoring margin trends and any deleveraging actions will be key to reassessing the investment case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below 20‑day SMA and negative MACD histogram
- Margin pressure despite earnings beat
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE suggests earnings improvement
- Analyst target price implies upside
- Defensive consumer sector offers stability
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated debt‑to‑equity ratio
- Dividend payout exceeds earnings
- Brand portfolio and market position remain solid
Key Metrics & Analysis
Financial Health
Revenue Growth0.80%
Profit Margin0.88%
P/E Ratio120.8
ROE2.32%
ROA4.06%
Debt/Equity193.10
P/B Ratio2.8
Op. Cash Flow$749.5M
Free Cash Flow$415.5M
Technical Analysis
TrendBullish
RSI50.4
Support$22.06
Resistance$25.28
MA 20$23.64
MA 50$21.27
MA 200$20.21
MACDBearish
VolumeStable
Fear & Greed Index83.02
Valuation
Fair Value$0.71
Target Price$27.18
Upside/Downside18.44%
GradeOvervalued
TypeBlend
Dividend Yield2.09%
Risk Assessment
Beta0.72
Volatility48.89%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.